SCHEMBL486121

SCHEMBL486121

O=C(NC1CCC1)c1cc(F)c2ccccc2c1OCc1nc2ccccc2s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.47
CXCR6 O00574 1/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
ALOX5AP P20292 1/20 0.45
FEN1 P39748 1/20 0.45
NPC1 O15118 4/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
RAB9A P51151 5/20 0.43
KMT2A Q03164 4/20 0.42
GAA P10253 1/20 0.42
ALOX5 P09917 1/20 0.41
EPHX2 P34913 1/20 0.41
MEN1 O00255 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL28768792 0.97 MAOB (0.45) MAOBCXCR6ALDH1A1SMN1; SMN2KDM4E
SCHEMBL485800 0.87 KMT2A (0.49) MAOBCXCR6ALDH1A1SMN1; SMN2KDM4E
SCHEMBL486027 0.87 MAOB (0.50) MAOBCXCR6ALDH1A1SMN1; SMN2KDM4E
Formic Acid SCHEMBL27693206 0.85 MAOB (0.47) MAOBCXCR6ALDH1A1SMN1; SMN2KDM4E
SCHEMBL485598 0.85 MAOB (0.53) MAOBCXCR6ALDH1A1SMN1; SMN2KDM4E
SCHEMBL486258 0.83 MAOB (0.52) MAOBCXCR6ALDH1A1SMN1; SMN2KDM4E
Formic Acid SCHEMBL27693254 0.81 MAOB (0.48) MAOBCXCR6ALDH1A1SMN1; SMN2KDM4E
SCHEMBL485680 0.81 CXCR2 (0.52) ALDH1A1SMN1; SMN2ALOX5APFEN1NPC1
Bicarbonate SCHEMBL485447 0.81 MAOB (0.50) MAOBCXCR6ALDH1A1SMN1; SMN2KDM4E
SCHEMBL28768791 0.80 NPC1 (0.41) ALDH1A1SMN1; SMN2KDM4EALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836158-B1 FUSED BICYCLIC CARBOXAMIDE DERIVATIVES FOR USE AS CXCR2 INHIBITORS IN THE TREATMENT OF INFLAMMATION SANOFI AVENTIS DEUTSCHLAND (DE) 2012-02-01 EP claimed